estradurin 80 mg pulver och vätska till injektionsvätska, lösning
pharmanovia a/s - mepivakainhydroklorid; polyestradiolfosfat - pulver och vätska till injektionsvätska, lösning - 80 mg - mepivakainhydroklorid 5 mg aktiv substans; polyestradiolfosfat 80 mg aktiv substans - polyöstradiolfosfat
amlodipin heumann 10 mg tablett
yes pharmaceutical development services gmbh - amlodipinmaleat - tablett - 10 mg - laktosmonohydrat hjälpämne; amlodipinmaleat 12,8 mg aktiv substans - amlodipin
amlodipin heumann 5 mg tablett
yes pharmaceutical development services gmbh - amlodipinmaleat - tablett - 5 mg - amlodipinmaleat 6,4 mg aktiv substans; laktosmonohydrat hjälpämne - amlodipin
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxorubicinhydroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiska medel - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
chirocaine 0,625 mg/ml infusionsvätska, lösning
abbvie ab - levobupivakainhydroklorid - infusionsvätska, lösning - 0,625 mg/ml - levobupivakainhydroklorid 0,7 mg aktiv substans - levobupivakain
chirocaine 1,25 mg/ml infusionsvätska, lösning
abbvie ab - levobupivakainhydroklorid - infusionsvätska, lösning - 1,25 mg/ml - levobupivakainhydroklorid 1,41 mg aktiv substans - levobupivakain
propess 10 mg vaginalinlägg
ferring läkemedel ab - dinoproston - vaginalinlägg - 10 mg - dinoproston 10 mg aktiv substans - dinoproston
rapydan 70 mg/70 mg medicinskt plåster
eurocept international b.v. - lidokain; tetrakain - medicinskt plåster - 70 mg/70 mg - lidokain 70 mg aktiv substans; borax hjälpämne; propylparahydroxibensoat hjälpämne; metylparahydroxibensoat hjälpämne; tetrakain 70 mg aktiv substans - kombinationer
erlotinib orion 100 mg filmdragerad tablett
orion corporation - erlotinibhydroklorid - filmdragerad tablett - 100 mg - erlotinibhydroklorid 109,3 mg aktiv substans; laktos (vattenfri) hjälpämne
erlotinib orion 25 mg filmdragerad tablett
orion corporation - erlotinibhydroklorid - filmdragerad tablett - 25 mg - erlotinibhydroklorid 27,3 mg aktiv substans; laktos (vattenfri) hjälpämne